Cancer Therapeutic Resistance: Progress and Perspectives (April 7-8, 2016 - Barcelona, Spain)

Area of Science:

• Oncology
• Cancer Research
• Pharmacology

Background:

• Tumor resistance to cancer therapies presents a significant clinical challenge.
• Understanding intrinsic and acquired resistance mechanisms is crucial for effective treatment.

Framework:

• The conference focused on integrating cancer omics, molecular classification, and clinically relevant tumor models.
• Exploration of novel therapeutic targets and biomarkers for resistance prediction.

Implementation:

• Discussions highlighted personalized medicine approaches to guide cancer treatment strategies.
• Leveraging high-throughput screening techniques to identify resistance patterns.

Implications:

• Progress in predicting and identifying drug resistance can lead to tangible patient benefits.
• Translational research aims to bridge the gap between laboratory findings and clinical application for cancer patients.